Literature DB >> 33748943

Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapy.

Chutima Kunacheewa1, Lei Feng2, Elisabet E Manasanch1, Qaiser Bashir3, Krina K Patel1, Rohtesh Mehta3, Gregory P Kaufman1, Samer Srour3, Neeraj Saini3, Swaminathan P Iyer1, Sheeba K Thomas1, Donna M Weber1, Robert Z Orlowski1, Muzaffar H Qazilbash2, Hans C Lee1.   

Abstract

Entities:  

Year:  2021        PMID： 33748943     DOI： 10.1111/bjh.17393

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

Review 1.  Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma.

Authors:  Linda Heimberg; Stefan Knop
Journal:  Oncol Res Treat       Date:  2021-11-18       Impact factor: 2.825

2.  Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis.

Authors:  Hira Mian; Christine Eisfeld; Christopher P Venner; Esther Masih-Khan; Moustafa Kardjadj; Victor H Jimenez-Zepeda; Cyrus Khandanpour; Georg Lenz; Arleigh McCurdy; Michael Sebag; Kevin Song; Richard LeBlanc; Darrell White; Julie Stakiw; Anthony Reiman; Martha Louzada; Muhammad Aslam; Rami Kotb; Engin Gul; Donna Reece
Journal:  Front Oncol       Date:  2022-02-18       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.